BIOCAD Announces Impending Approval of its Rituximab Biosimilar in India

Published date07 July 2017
Law FirmGoodwin
Subject MatterBiotechnology,Prescription Drugs,India,Commercial Marketing,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT